Dolby Laboratories (MEX:DLB) 1-Year Sharpe Ratio: -1.94 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DLB Dolby Laboratories Inc MEX:DLB
73 GF Score
Price MXN933.45
GF Value MXN1,548.00
! 2 Warning Signs
View Full Analysis

What is Dolby Laboratories 1-Year Sharpe Ratio?

Dolby Laboratories MEX:DLB 73 1-Year Sharpe Ratio is -1.94 as of Aug. 01, 2026. GuruFocus rates MEX:DLB with a GF Score™ of 73/100 and a GF Value™ of MXN1,548.00. The stock has 2 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-01), Dolby Laboratories's 1-Year Sharpe Ratio is -1.94.


Dolby Laboratories  (MEX:DLB) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Dolby Laboratories 1-Year Sharpe Ratio Related Terms


MEX:DLB vs AZZ, UNF, AMTM: 1-Year Sharpe Ratio Comparison

For the Specialty Business Services subindustry, Dolby Laboratories's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dolby Laboratories 1-Year Sharpe Ratio vs Business Services Industry

For the Business Services industry and Industrials sector, Dolby Laboratories's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Dolby Laboratories's 1-Year Sharpe Ratio falls into.


MEX:DLB
73GF Score
Dolby Laboratories Inc MEX:DLB
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dolby Laboratories 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -1.94 mean?
Dolby Laboratories (MEX:DLB) has a 1-Year Sharpe Ratio of -1.94 as of Aug. 01, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Dolby Laboratories and its competitors.
Is Dolby Laboratories' 1-Year Sharpe Ratio too high?
Dolby Laboratories' current 1-Year Sharpe Ratio is -1.94. Overall, Dolby Laboratories has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Dolby Laboratories' 1-Year Sharpe Ratio compare to AZZ and UNF?
Dolby Laboratories' 1-Year Sharpe Ratio of -1.94 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Business Services company?
A good 1-Year Sharpe Ratio depends on the Business Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Dolby Laboratories and its competitors. Dolby Laboratories's current 1-Year Sharpe Ratio is -1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolby Laboratories stock overvalued right now?
Dolby Laboratories (MEX:DLB) has a current 1-Year Sharpe Ratio of -1.94. The stock's GF Value™ is MXN1,548.00, compared to a current price of MXN933.45 — trading 39.7% below its estimated fair value. The current 1-Year Sharpe Ratio is -1.94. Dolby Laboratories' overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Dolby Laboratories (MEX:DLB), the current 1-Year Sharpe Ratio is -1.94 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dolby Laboratories (MEX:DLB) Overvalued in 2026?

Based on GuruFocus' analysis, Dolby Laboratories stock appears to be undervalued. The current stock price of MXN933.45 is trading 39.7% below its estimated GF Value™ of MXN1,548.00.

Key valuation signals for MEX:DLB:

  • 1-Year Sharpe Ratio: -1.94
  • GF Value™: MXN1,548.00 vs. price of MXN933.45 (39.7% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the MEX:DLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dolby Laboratories Business Description

Address 1275 Market Street, San Francisco, CA, USA, 94103-1410
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
73GF Score

Get the complete analysis for MEX:DLB

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN933.45
Price
MXN1,548.00
GF Value